IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 56 filers reported holding IMMUNIC INC in Q3 2023. The put-call ratio across all filers is 15.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184,930 | -41.4% | 125,803 | 0.0% | 0.00% | – |
| Q2 2023 | $315,766 | +68.5% | 125,803 | 0.0% | 0.00% | – |
| Q1 2023 | $187,446 | -13.3% | 125,803 | -18.5% | 0.00% | – |
| Q4 2022 | $216,168 | +3.9% | 154,406 | +134.3% | 0.00% | – |
| Q3 2022 | $208,000 | -9.2% | 65,903 | 0.0% | 0.00% | – |
| Q2 2022 | $229,000 | -93.7% | 65,903 | -79.4% | 0.00% | – |
| Q1 2022 | $3,611,000 | -18.7% | 319,575 | -31.1% | 0.00% | – |
| Q4 2021 | $4,440,000 | +13.8% | 464,000 | +5.2% | 0.00% | – |
| Q3 2021 | $3,902,000 | -9.4% | 440,944 | +25.5% | 0.00% | – |
| Q2 2021 | $4,307,000 | +8.5% | 351,296 | +41.1% | 0.00% | – |
| Q1 2021 | $3,969,000 | +200.7% | 249,019 | +188.6% | 0.00% | – |
| Q4 2020 | $1,320,000 | +0.6% | 86,300 | +22.2% | 0.00% | – |
| Q3 2020 | $1,312,000 | +224.8% | 70,625 | +111.7% | 0.00% | – |
| Q2 2020 | $404,000 | – | 33,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
| Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
| INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
| Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
| RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
| Logos Global Management LP | 421,184 | $619,140 | 0.08% |
| Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
| BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
| Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
| COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |